You are here
AdvaMed Statement on House 21st Century Cures Hearing
WASHINGTON, D.C. – Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed) issued the following statement on today’s House Energy and Commerce Health Subcommittee 21st Century Cures hearing:
“AdvaMed applauds the subcommittee for holding this important hearing on barriers to evidence development and improving communication and collaboration among patients, providers, researchers, and medical technology companies to ensure continued development of the latest treatments and cures.
“Medical technology has helped millions of Americans lead longer, healthier, more productive lives, and future advancements hold the promise to improve patient outcomes even more and to impact the real driver of health care costs – chronic disease.
“Moreover, recent research from the Milken Institute demonstrates that medical technology gives a significant boost to the U.S. economy, expanding U.S. GDP by $106.2 billion in 2010 by reducing the burden of illness on disability and allowing patients and their caregivers to return to leading productive lives.
“Collaboration among patients, physicians, medical technology companies and other stakeholders is crucial to generating the evidence necessary to support the next generation of medical innovations. However, numerous barriers and challenges stand in the way of evidence gathering and threaten patient access to the latest treatments and cures.
“Edwards Lifesciences Chairman and CEO Michael A. Mussallem discussed with the panel ways of improving patient access to the latest treatments and technology advances based on Edwards’ experience in developing and delivering new life-saving therapies to American patients over the last several decades.
“AdvaMed looks forward to working with members of Congress and other stakeholders to address these issues to facilitate the processes for developing the next generation of life-changing innovations.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies.